MedTrace Logo

Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias

NCT04649320 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-12-02

No results posted yet for this study

Summary

Cancer patients are among the most vulnerable individuals, whose health-related quality of life (HRQOL) may be substantially impacted by the COVID19 pandemic. We want to study how the COVID-19 pandemic influences the life of cancer patients and how these patients cope with the additional distress with the aim to facilitate the development of improved future interventional strategies to maintain resilience and HRQOL

Conditions

  • Covid19

Interventions

OTHER

questionnaire

1. 13-item questionnaire about cancer patient's distress and everyday life, 2. EORTC-QLQ-C30

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Reinhard Stauder, M.D. · Medical University of Innsbruck, Anichstraße 35, A-6020 Innsbruck, Austria

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04649320 on ClinicalTrials.gov